Baptist Health Lexington — soon to become a major corporate neighbor in Lexington’s rapidly growing Hamburg neighborhood — has announced that they will be the first hospital in Lexington and among the first in the state to adopt the use of Tenecteplase (TNK), a fast-acting clot-busting medication for stroke patients. 
“Tenecteplase (TNK) can be administered in 5 seconds, saving millions of brain cells while specifically targeting the clot,” said Murali Kolikonda, MD, Baptist Health Lexington stroke neurologist. “We are beyond thrilled to raise the level of care for our stroke patients in the community and see the benefits of this medication.”
As a Joint Commission Comprehensive Stroke Center, Baptist Health Lexington offers a complete spectrum of solutions to patients living with cerebrovascular disease. Our team of specialists is trained to provide neurology, neurosurgery and stroke care, including advanced treatments in carotid disease, interventional stroke capabilities, neuro-interventional radiology and an expanded stroke research program.
This story appears in Hamburg Journal’s monthly health section in the March 2022 print edition. Call today to advertise in HJ’s monthly health section.
